CHITI, ARTURO

CHITI, ARTURO  

Dipartimento Scienze Biomediche  

Mostra records
Risultati 1 - 20 di 330 (tempo di esecuzione: 0.03 secondi).
Titolo Data di pubblicazione Autore(i) File
111In-DTPA-D-Phe-1-octreotide scintigraphy of small cell lung cancer. 1-gen-1995 Bombardieri, E; Chiti, A; Crippa, F; Seregni, E; Cataldo, I; Maffioli, L; Soresi, E
111In-octreotide uptake in granulomatous and tumor lesions in a patient with small-cell lung cancer 1-gen-1994 Crippa, F; Bombardieri, E; Chiti, A; Soresi, E; Boffi, R; Buraggi, Gl
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 1-gen-2017 Franzese, C; Lopci, E; Di Brina, L; D'Agostino, Gr; Navarria, P; Mancosu, P; Tomatis, S; Chiti, A; Scorsetti, M
11Cl-choline PET/CT in imaging locally advanced prostate cancer 1-gen-2011 Rodari, M.; Lopci, E; Pepe, G; Antunovic, L; Chiti, A
18F-FDG PET and CT scan in the pre-operative evaluation of colorectal liver metastases treated with chemotherapy 1-gen-2006 Rimassa, L.; Chiti, A.; Carnaghi, C.; Doci, R.; Torzilli, G; Zuradelli, M.; Tondulli, L.; Pressiani, T.; Lutman, F. R.; Tronconi, M. C.; Santoro, A.
18F-FDG pet does not improve contrast enhanced CT scan sensitivity in the evaluation of liver metastases after chemotherapy 1-gen-2006 Carnaghi, Carlo; Chiti, Arturo; Rimassa, Lorenza; Zuradelli, Monica; Tondulli, Luca; Torzilli, G; Doci, Roberto; Tronconi Maria, Chiara; Pressiani, Tiziana; Santoro, Armando
68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY 1-gen-2018 Lazzeri, M; Lopci, E; Lughezzani, G; Buffi, N; Casale, P; Hurle, R; Saita, A; Peschechera, R; Benetti, A; Pasini, L; Zandegiacomo, S; Lista, G; Cardone, P; Chiti, A; Guazzoni, G
A case of atypical giant cell arteritis diagnosed by positron emission tomography (PET) 1-gen-2008 Belloli, L; Rodari, M; Massarotti, M; Conciato, L; Chiti, A; Marasini, B
A case of metastatic axillary lymph nodes involvement from unknown primary cancer: Clinical usefulness of [Tc-99m]-sestamibi 1-gen-1998 Chiti, A; Di Nicola, M; Spinelli, A; Siena, S; Bregni, M; Savelli, G; Gianni, Ma; Bombardieri, E
A DOUBTFUL IMAGE OF LEVEEN SHUNT PATENCY 1-gen-1993 Chiti, A; Castellani, M; Intra, M; Bestetti, A; Giovanella, Lc; Maioli, C; Tarolo, Gl
A method to reduce acetonitrile amount in F-18-FDG synthesis 1-gen-2004 Marzo, K; Bovone, P; Tosi, G; Chiti, A
A portrait of the scientist as a young woman Comments after the first EANM Young Investigators' Meeting 1-gen-2009 Chiti, A
A risk management approach for imaging biomarker-driven clinical trials in oncology 1-gen-2015 Liu, Y; Desouza, Nm; Shankar, Lk; Kauczor, Hu; Trattnig, S; Collette, S; Chiti, A
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions 1-gen-2018 Kirienko, M; Cozzi, L; Rossi, A; Voulaz, E; Antunovic, L; Fogliata, A; Chiti, A; Sollini, M
Absorbed dose from daily routine practice in a nuclear cardiology laboratory 1-gen-2007 Tosi, G; Marzo, K; Leonardi, L; Chiti, A
Absorbed dose from daily routine practice in an 18F-FDG producing radiopharmacy 1-gen-2006 Marzo, K; Tosi, G; Chiti, A
Advanced Imaging Supports the Mechanistic Role of Autoimmunity and Plaque Rupture in COVID-19 Heart Involvement 1-gen-2022 Laino, Maria Elena; Ammirabile, Angela; Motta, Francesca; De Santis, Maria; Savevski, Victor; Francone, Marco; Chiti, Arturo; Mannelli, Lorenzo; Selmi, Carlo; Monti, Lorenzo
Advancing EJNMMI: continuing success and next developments 1-gen-2018 Carrio, I; Chiti, A
Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate 1-gen-2018 Santoro, A; Castagna, L; Magagnoli, M; Bramanti, S; Mariotti, J; Mazza, R; Morello, L; Ricci, F; Sarina, B; De Philippis, C; Sica, S; Rodari, M; Sollini, M; Kirienko, M; Giordano, L; Chiti, A; Corradini, P; Carlo-Stella, C
Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer 1-gen-2018 Kirienko, M; Sollini, M; Silvestri, G; Mognetti, S; Voulaz, E; Antunovic, L; Rossi, A; Antiga, L; Chiti, A